Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Valeos Pharma A/S
A/S
Active
Advertising protection
CVR 39696614
Østervej 2, 4960
Holeby
Manufacture of basic pharmaceutical products
·
NACE 2110
Est. 2018 · 7 years old
19 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of basic pharmaceutical products
/
Valeos Pharma A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
PF
Peter Frederik Andreasen
Chief Executive Officer
Chief Executive Officer
2025
Former (3)
BS
Birgitte Steen Frydland
Chief Executive Officer
Chief Executive Officer
2021 – 2022
FJ
Farzad Jahanshahi
Chief Executive Officer
Chief Executive Officer
2022 – 2022
ML
Morten Larsen Snede
Chief Executive Officer
Chief Executive Officer
2024 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
GS
Glenn Steven Nielsen
Chairman
Chairman
2025
KS
Kristian Schrøder Hart-Hansen
Board of Directors
Board of Directors
2022
MH
Michael Halborg-Bendtsen
Board of Directors
Board of Directors
2019
Former (2)
HK
Henrik Kristian Moltke
Chairman
Chairman
2022 – 2025
MA
Michael Andreasen
Board of Directors
Board of Directors
2021 – 2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
MSG Capital APS
Company
50–66.65%
50–66.65%
2024
A. Rosen Holding ApS
Company
15–19.99%
15–19.99%
2024
Kleingut ApS
Company
10–14.99%
10–14.99%
2024
Novosato Holding ApS
Company
20–24.99%
20–24.99%
2020
Henriksholm 2018 ApS
Company
5–9.99%
5–9.99%
2021
Totti Hannu Miikael Vuosio
Individual
20–24.99%
20–24.99%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Valeos Pharma A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network